Luteinizing hormone-releasing hormone (LH-RH), or gonadotropin-releasing hormone (GnRH), is secreted by the hypothalamus and triggers the pituitary gland to release the hormones, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that make estrogen and progesterone in females and testosterone in males. Since some cancers require or respond to estrogen or testosterone in order to grow, agonists of LHRH are often used as treatment.1 Growth hormone releasing factor (GRF or GHRH) is important in many cellular processes and in sleep promotion. It was first isolated from a pancreatic tumor.1 And lastly, Human Chorionic Gonadotropin (hCG) is released during pregnancy, however, research has found that some tumors express it, making it a useful tumor marker.3,4 When circulated during pregnancy, it has also been found to provide long-term protective effects against breast cancer.5 The following are some of the neurohormones that Peptides International carries for cancer research, and are also included in the current sale.
Anti LH-RH (Human, Rat) Serum (50 ul)
Anti Pro-LH-RH (1-26) (Human) Serum (50 ul)
SRIF(Somatotropin Release Inhibiting Factor)/GIF(Growth Hormone Release Inhibiting Factor)
Stimulator of LH-HR/GnRH and gonadotropin secretion
Chorionic Gonadotropin Human (hCG)
Chorionic Gonadotropin Beta Human Recombinant
The entire archive of Peptides International Product Spotlights is available here. The topics range from some of the most popular items we have available to those lesser known ones that still have compelling research applications. They often are chosen due to recently published articles that feature them. They are permanently posted here, so read at your leisure!